The Hidden Power of Diabetes Drugs in Preserving Kidney Function
Type 2 diabetes is a prevalent metabolic disorder often associated with the progression of diabetic kidney disease (DKD), a leading ...
{"id":19337,"date":"2024-08-30T05:14:19","date_gmt":"2024-08-30T05:14:19","guid":{"rendered":"https:\/\/scienmag.com\/promising-antibiotic-candidates-discovered-in-microbes-deep-in-the-arctic-sea\/"},"modified":"2024-08-30T05:14:19","modified_gmt":"2024-08-30T05:14:19","slug":"promising-antibiotic-candidates-discovered-in-microbes-deep-in-the-arctic-sea","status":"publish","type":"post","link":"https:\/\/scienmag.com\/promising-antibiotic-candidates-discovered-in-microbes-deep-in-the-arctic-sea\/","title":{"rendered":"Promising antibiotic candidates discovered in microbes deep in the Arctic Sea"},"content":{"rendered":"
Antibiotics are the linchpin of modern medicine: without them, anyone with open wounds or needing to undergo surgery would be at constant risk of dangerous infections. Yet we continue to face a global antibiotics crisis, as more and more resistant strains of bacteria are evolving, while the rate of discovery of fundamentally new antibiotics has been much slower.<\/p>\n
<\/p>\n
Credit: Teppo R\u00e4m\u00e4<\/p>\n
<\/p>\n
Antibiotics are the linchpin of modern medicine: without them, anyone with open wounds or needing to undergo surgery would be at constant risk of dangerous infections. Yet we continue to face a global antibiotics crisis, as more and more resistant strains of bacteria are evolving, while the rate of discovery of fundamentally new antibiotics has been much slower.<\/p>\n
But there is reason for hope: 70% of all currently licensed antibiotics have been derived from actinobacteria in the soil, and most environments on Earth have not yet been prospected for them. Thus, focusing the search on actinobacteria in other habitats is a promising strategy \u2013 especially if this were to yield novel molecules that neither kill bacteria outright nor stop them from growing, but only reduce their \u2018virulence\u2019 or capacity for causing disease. This is because it is hard for targeted pathogenic strains to evolve resistance under these conditions, while such antivirulence compounds are also less likely to cause unwanted side-effects.<\/p>\n